Tuesday, 02 January 2024 12:17 GMT

Madbouly Reviews Strategy To Localize Pharmaceutical Industry, Ensure Drug Supply


(MENAFN- Daily News Egypt) Egyptian Prime Minister Mostafa Madbouly on Sunday chaired a meeting to review national efforts to secure the supply of medicines and medical products, and to advance the localization of the pharmaceutical industry, according to a statement from the Cabinet.

The meeting was attended by Health Minister Khaled Abdel Ghaffar, Finance Minister Ahmed Kouchouk, Investment and Foreign Trade Minister Hassan El-Khatib, as well as the heads of the Egyptian Drug Authority and the Unified Procurement Authority, along with other senior officials.

Madbouly stressed that the government is holding regular meetings to ensure a sufficient supply of essential medicines for both citizens and healthcare institutions, while also maintaining a safe strategic stockpile. He noted ongoing coordination among relevant agencies to secure financing for pharmaceutical raw materials and to settle outstanding dues owed to pharmaceutical companies.

He affirmed that the pharmaceutical sector remains a top priority under President Abdel Fattah Al-Sisi's directives, which call for the localization of pharmaceutical production using advanced technologies and through partnerships with international companies. The objective, he said, is to meet local demand while expanding Egypt's pharmaceutical exports, particularly to African markets.

According to the Cabinet statement, the meeting also reviewed the Egyptian Drug Authority's ongoing efforts to implement international quality standards and achieve global accreditation in collaboration with specialized organizations. Officials further discussed strategies to attract foreign investment into the pharmaceutical and medical supplies sectors, with the aim of enhancing local production capacity and improving the availability of essential medicines in the domestic market.

MENAFN14092025000153011029ID1110060291

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.

Search